OnabotulinumtoxinA for Hemicrania Continua:open label experience in 9 patients
25.01.2016
We present our experience of nine patients treated with OnabotulinumtoxinA for hemicraniacontinua. All patients were injected using the PREEMPT (Phase 3 REsearch Evaluating Migraine ProphylaxisTherapy) protocol for migraine.
Автор: Sarah Miller Fernando Correia, Susie Lagrata and Manjit S Matharu
Год публикации: 2015
Файл: Загрузить